Erythema multiforme major secondary to a cosmetic facial cream: first case report

2016 ◽  
Vol 121 (1) ◽  
pp. e10-e15 ◽  
Author(s):  
Andre A. Farquharson ◽  
Eric T. Stoopler ◽  
Alicia M. Houston ◽  
Ronald S. Brown
Keyword(s):  
Case Report ◽  
Erythema Multiforme ◽  
First Case ◽  
Erythema Multiforme Major

scholarly journals Erythema Multiforme Major Associated With Community-Acquired Pneumonia: Lessons From a Case Report

2021 ◽  
Vol 9 ◽  
Author(s):  
Xiaomei Fan ◽  
Yong Luo ◽  
Jieluan Lu ◽  
Jinji Xu ◽  
Qing Chen ◽  
...  
Keyword(s):  
Case Report ◽  
Erythema Multiforme ◽  
Clinical Symptoms ◽  
Specific Treatment ◽  
Human Leukocyte ◽  
Community Acquired Pneumonia ◽  
The Body ◽  
Drug Induced ◽  
Chemical Structures ◽  
Erythema Multiforme Major

Background: Erythema multiforme (EM) is an acute immune-mediated inflammatory mucinous skin disorder. The etiology of pediatric EM involves infections, medications, autoimmune diseases, and genetic factors.Case Report: An 8-year-old girl with Mycoplasma pneumoniae (MP) associated community-acquired pneumonia developed erythema target-like symptoms 1 week after azithromycin administration. The erythema quickly spread throughout the body involving the oral and ocular mucous membranes, the trunk, and the extremities, and eventually developed into erythema multiform major (EMM). Through drug withdrawal and specific treatment including systemic corticosteroids and supportive care, her clinical symptoms were improved. After 31 days, most of the mucocutaneous symptoms were relieved, except pigmentation. Human leukocyte antigen (HLA) gene sequencing was performed and 20 HLA genotypes were identified. The patient follow-up lasted for 18 months. Rashes appeared on her trunk when receiving azithromycin orally after discharge and then disappeared after azithromycin withdrawal.Conclusions: Pediatric EM is a rare disease and recognition of its etiology is important for EM management. In this case, azithromycin and HLA-DQB1*03:01 genotype may contribute to EMM.Lesson: For drug-induced EM, rapid identification and withdrawal of the causative drugs is critical. Re-exposure to the same drug or exposure to drugs with similar chemical structures should also be avoided. Patient education and rational use of medicines are essential for pediatric patients.

scholarly journals Erythema multiforme major after treatment with bosutinib: a case report

2016 ◽  
Vol 27 ◽  
pp. vii105
Author(s):  
Junya Makiyama ◽  
Hideki Kitanosono ◽  
Yuji Moriwaki ◽  
Tetsuo Shukuwa ◽  
Shinichiro Yoshida
Keyword(s):  
Case Report ◽  
Erythema Multiforme ◽  
Erythema Multiforme Major

scholarly journals Dermatologic and Ophthalmologic Treatment of Erythema Multiforme Major: A Case Report

Cureus ◽  
2021 ◽  
Author(s):  
Barbara Senger ◽  
Shayan A Memar ◽  
Alex Ahmann ◽  
Jeremy J Houser ◽  
Lauren Doughty-McDonald
Keyword(s):  
Case Report ◽  
Erythema Multiforme ◽  
Erythema Multiforme Major

Papular perniosis mimicking erythema multiforme: the first case report in Thailand

2000 ◽  
Vol 39 (7) ◽  
pp. 527-529 ◽  
Author(s):  
Phongsakorn Wessagowit ◽  
Pravit Asawanonda ◽  
Nopadon Noppakun
Keyword(s):  
Case Report ◽  
Erythema Multiforme ◽  
First Case

scholarly journals  Erythema multiforme minor in a dog following inappropriate intranasal Bordetella bronchiseptica vaccination: a case report

2011 ◽  
Vol 56 (No. 11) ◽  
pp. 568-572 ◽  
Author(s):  
MH Kang ◽  
HM Park
Keyword(s):  
Case Report ◽  
Erythema Multiforme ◽  
Clinical Signs ◽  
Skin Lesions ◽  
Bordetella Bronchiseptica ◽  
Hydropic Degeneration ◽  
First Case ◽  
History Of ◽  
One Year

A one-year-old, intact female, Yorkshire terrier dog was presented with a six-month history of multifocal, polycyclic erythematous lesions with epidermal collarette formation at the axillae, the trunk and ventral abdomen. The dog had a history of an inappropriate vaccine administration one day prior to the onset of clinical signs. The histopathology of the lesions revealed apoptosis of keratinocytes in the overlying epidermis, hydropic degeneration and lymphocytic exocytosis. The clinical signs and histopathology of the lesions were compatible with erythema multiforme. The skin lesions resolved after treatment with prednisolone combined with azathioprine for one month. No recurrence of clinical signs occurred during the follow-up period (four months). This is the first case report of erythema multiforme associated with an accidental subcutaneous injection of a Bordetella bronchiseptica vaccine.  

scholarly journals Erythema Multiforme- Case Report with Review

2014 ◽  
Vol 02 (03) ◽  
pp. 166-168
Author(s):  
Neha Gupta ◽  
Amol Bansal ◽  
Aarti Bansal
Keyword(s):  
Case Report ◽  
Hypersensitivity Reaction ◽  
Toxic Epidermal Necrolysis ◽  
Cytotoxic T Lymphocytes ◽  
Erythema Multiforme ◽  
Wide Spectrum ◽  
Cell Necrosis ◽  
Erythema Multiforme Major ◽  
Life Threatening ◽  
Inflammatory Drugs

AbstractErythema Multiforme is a rare, acute, inflammatory mucocutaneous condition caused by a hypersensitivity reaction with the appearance of cytotoxic T lymphocytes in the epithelium that induce apoptosis in keratinocytes, which leads to satellite cell necrosis. Reactions to drugs are quite common and are generally mild, hence not reported. However, occasionally life threatening reactions including Erythema multiforme major (Steven Johnson’s syndrome) and Toxic Epidermal Necrolysis may occur. A wide spectrum of drugs can sometimes give rise to Erythema Multiforme. We report a case of Erythema Multiforme following administration of Non Steroidal Anti-Inflammatory Drugs.

scholarly journals Anaphylaxis preceded by erythema multiforme with sorafenib: First case report

2019 ◽  
Vol 18 (5) ◽  
pp. 777-779 ◽  
Author(s):  
Augusto Mantovani ◽  
Mário Reis Álvares-Da-Silva
Keyword(s):  
Case Report ◽  
Erythema Multiforme ◽  
First Case

The first case report of Pembrolizumab inducing thyroiditis and hypophysitis

2020 ◽  
Author(s):  
Rahman Maraqa Sima Abdel ◽  
Robert McMahon ◽  
Anusha Pinjala ◽  
Gastelum Alheli Arce ◽  
Mohsen Zena
Keyword(s):  
Case Report ◽  
First Case

Harel-Yoon syndrome: the first case report from Saudi Arabia

2020 ◽  
pp. 22-27 ◽  
Author(s):  
Alaa AlAyed ◽  
Manar Samman ◽  
Abdul Peer-Zada ◽  
Mohammed Almannai
Keyword(s):  
Saudi Arabia ◽  
Case Report ◽  
First Case
Sign in / Sign up

Export Citation Format

Share Document